Literature DB >> 1525659

Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists.

J Y Koh1, C W Cotman.   

Abstract

Organic calcium channel antagonists attenuate ischemic or excitotoxic neuronal injury, probably by limiting Ca2+ influx through the voltage-gated calcium channels. However, the possibility that calcium channel antagonists may compromise neuronal survival with long-term exposure has not been systemically examined. In the present study, we report that cerebral cortical cultures exposed for 2 days to either nifedipine, verapamil, diltiazem, or flunarizine, undergo selective neuronal degradation in a concentration-dependent fashion. This degeneration could be attenuated by protein synthesis inhibitors cycloheximide and actinomycin-D. Cortical cultures incubated for 2 days in low calcium media also exhibit widespread neuronal damage, which is similarly blocked by cycloheximide. Although we cannot exclude other possibilities, these findings suggest that a decrease in intraneuronal calcium levels may trigger synthesis of proteins mediating neuronal cell death. Regardless of the exact toxic mechanisms involved, additional studies on neurotoxicity of calcium channel antagonists seem warranted since some of these compounds are currently being clinically used.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525659     DOI: 10.1016/0006-8993(92)91002-v

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis.

Authors:  H M Schätzl; L Laszlo; D M Holtzman; J Tatzelt; S J DeArmond; R I Weiner; W C Mobley; S B Prusiner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Loss of calcium and increased apoptosis within the same neuron.

Authors:  C P Turner; J Connell; K Blackstone; S L Ringler
Journal:  Brain Res       Date:  2006-11-22       Impact factor: 3.252

3.  Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists.

Authors:  J L Nargi-Aizenman; D E Griffin
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

5.  Progressive ataxia due to a missense mutation in a calcium-channel gene.

Authors:  Q Yue; J C Jen; S F Nelson; R W Baloh
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

6.  HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation in Vitro and in Vivo.

Authors:  Jingji Jin; Bethany Grimmig; James Izzo; Lecia A M Brown; Charles Hudson; Adam J Smith; Jun Tan; Paula C Bickford; Brian Giunta
Journal:  Cell Transplant       Date:  2016-11       Impact factor: 4.064

7.  Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.

Authors:  Catlyn Blanchard; Pamela Barnett; Jessamyn Perlmutter; Paul M Dunman
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

8.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

Authors:  D T Loo; A Copani; C J Pike; E R Whittemore; A J Walencewicz; C W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Decline in age-dependent, MK801-induced injury coincides with developmental switch in parvalbumin expression: somatosensory and motor cortex.

Authors:  Carla M Lema Tomé; Ryan Miller; Clayton Bauer; Chelsey Smith; Kaitlin Blackstone; Adam Leigh; Jamie Busch; Christopher P Turner
Journal:  Dev Psychobiol       Date:  2008-11       Impact factor: 3.038

10.  Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line.

Authors:  R G Smith; M E Alexianu; G Crawford; O Nyormoi; E Stefani; S H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.